Relay Therapeutics (RLAY) PT Lowered to $34 at Stifel
Tweet
Share
E-mailGet Alerts RLAY Hot Sheet
Price: $19.86 -0.35%
Rating Summary:
16 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
16 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Stifel analyst Bradley Canino lowered the price target on Relay Therapeutics (NASDAQ: RLAY) to $34.00 (from $38.00) while maintaining a Buy rating.
You May Also Be Interested In
- Relay Therapeutics (RLAY) PT Raised to $31 at JPMorgan
- Va Tech Wabag Ltd. (VATW:IN) PT Raised to INR2,410 at ICICI Securities
- Lithium Ionic Corp (LTH:CN) PT Lowered to Cdn$2.50 at Desjardins
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
